Biotech Unicorn New Horizon Health Receives China’s First Early Cancer Screening Approval from NMPA New Horizon Health on Nov. 25 announced that their flagship product, ColoClear, has been approved by the National Medical Products Administration for the screening of Colorectal Cancer (CRC) and precancerous lesion.
